Jiangsu Lanfeng Bio-chemical Co.,Ltd (SHE:002513)
China · Delayed Price · Currency is CNY 7.40
+0.24 (3.35%)
Feb 6, 2026, 3:04 PM CST
SHE:002513 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -144.65 | -252.5 | -332.26 | -320.69 | -491.19 | 14.82 |
Depreciation & Amortization | 123.35 | 123.35 | 98.22 | 95.81 | 116.36 | 123.87 |
Other Amortization | 0.8 | 0.8 | 0.01 | 0.01 | 0.15 | 1.8 |
Loss (Gain) From Sale of Assets | 0.36 | 0.36 | 1.46 | -1.47 | 12.1 | -23.55 |
Asset Writedown & Restructuring Costs | - | - | 92.61 | - | 281.33 | 10.19 |
Loss (Gain) From Sale of Investments | -1.21 | -1.21 | -31.62 | -2.31 | -1.79 | -36.77 |
Provision & Write-off of Bad Debts | 20.13 | 20.13 | 7.68 | 0.42 | 25.61 | 3.7 |
Other Operating Activities | -349.63 | 53.08 | 43.54 | 81.27 | 49.71 | 37.22 |
Change in Accounts Receivable | 291.2 | 291.2 | -405.32 | -36.18 | 56.65 | 488.92 |
Change in Inventory | -88.65 | -88.65 | -86.46 | 18.66 | -25.48 | 11.09 |
Change in Accounts Payable | 47.45 | 47.45 | 252.07 | 26.64 | 26.84 | -486.02 |
Change in Other Net Operating Assets | -9.17 | -9.17 | 3.47 | 0.34 | 9.89 | -3.55 |
Operating Cash Flow | -188.68 | 106.18 | -383.3 | -64.34 | 11.8 | 128.31 |
Operating Cash Flow Growth | - | - | - | - | -90.81% | -49.70% |
Capital Expenditures | -151.42 | -277.24 | -468.36 | -31.09 | -88.88 | -107.72 |
Sale of Property, Plant & Equipment | 2.01 | 0.99 | 2.2 | 7.36 | 3.67 | 52.61 |
Cash Acquisitions | -3.6 | - | -59.29 | - | - | - |
Divestitures | 10.65 | 9.92 | 9.65 | 60 | - | 258.2 |
Investment in Securities | - | - | - | -37.6 | -10 | - |
Other Investing Activities | 44.19 | 43.75 | -21 | -8.42 | - | 17.57 |
Investing Cash Flow | -98.17 | -222.59 | -536.79 | -9.76 | -95.21 | 220.66 |
Short-Term Debt Issued | - | 389.9 | 1,075 | 171.14 | 271.4 | 306.17 |
Long-Term Debt Issued | - | 335.19 | 615.31 | - | - | - |
Total Debt Issued | 412.24 | 725.09 | 1,691 | 171.14 | 271.4 | 306.17 |
Short-Term Debt Repaid | - | -400.25 | -686.68 | -163.96 | -264.32 | -444.4 |
Long-Term Debt Repaid | - | -542.71 | -209.9 | -51.62 | -103.88 | -112.42 |
Total Debt Repaid | -772.89 | -942.97 | -896.58 | -215.58 | -368.2 | -556.82 |
Net Debt Issued (Repaid) | -360.64 | -217.88 | 794.17 | -44.45 | -96.8 | -250.65 |
Issuance of Common Stock | 25.38 | 40.24 | - | 101.55 | - | - |
Repurchase of Common Stock | -55.87 | -55.87 | -11.69 | - | - | - |
Common Dividends Paid | -24.82 | -29.4 | -12.07 | -6 | -12.65 | -15.61 |
Other Financing Activities | 722.08 | 420.52 | 155.52 | -3.28 | - | - |
Financing Cash Flow | 306.13 | 157.61 | 925.94 | 47.83 | -109.45 | -266.26 |
Foreign Exchange Rate Adjustments | 7.14 | 8.17 | 1.08 | 2.27 | -0.96 | -6.1 |
Net Cash Flow | 26.41 | 49.37 | 6.94 | -23.99 | -193.83 | 76.61 |
Free Cash Flow | -340.1 | -171.06 | -851.66 | -95.43 | -77.08 | 20.58 |
Free Cash Flow Growth | - | - | - | - | - | -87.39% |
Free Cash Flow Margin | -15.49% | -9.54% | -48.90% | -6.60% | -5.34% | 1.53% |
Free Cash Flow Per Share | -0.90 | -0.46 | -2.28 | -0.26 | -0.23 | 0.06 |
Cash Income Tax Paid | - | -121.1 | -0.08 | -38.13 | -56.11 | -6.93 |
Levered Free Cash Flow | 503.2 | -359.7 | 56.08 | 81.48 | 35.34 | -187.72 |
Unlevered Free Cash Flow | 542.28 | -322.5 | 72.66 | 89.95 | 49.46 | -168.46 |
Change in Working Capital | 162.16 | 162.16 | -262.95 | 82.63 | 19.52 | -2.98 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.